Synmosa Biopharma (ROCO:4114) Change In Receivables : NT$-78 Mil (TTM As of Mar. 2025)

View and export this data going back to 2003. Start your Free Trial

What is Synmosa Biopharma Change In Receivables?

Synmosa Biopharma's change in receivables for the quarter that ended in Mar. 2025 was NT$12 Mil. It means Synmosa Biopharma's Accounts Receivable declined by NT$12 Mil from Dec. 2024 to Mar. 2025 .

Synmosa Biopharma's change in receivables for the fiscal year that ended in Dec. 2024 was NT$-95 Mil. It means Synmosa Biopharma's Accounts Receivable increased by NT$95 Mil from Dec. 2023 to Dec. 2024 .

Synmosa Biopharma's Accounts Receivable for the quarter that ended in Mar. 2025 was NT$1,151 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Synmosa Biopharma's Days Sales Outstanding for the three months ended in Mar. 2025 was 72.57.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Synmosa Biopharma's liquidation value for the three months ended in Mar. 2025 was NT$564 Mil.

Synmosa Biopharma Change In Receivables Historical Data

The historical data trend for Synmosa Biopharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synmosa Biopharma Change In Receivables Chart

Synmosa Biopharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-2.71

-98.93

-280.39

-29.16

-95.09

Synmosa Biopharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-5.75	-15.31	-19.22	-54.81	11.71

Synmosa Biopharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-78 Mil.

Synmosa Biopharma (ROCO:4114) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Synmosa Biopharma's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1151.151	/	1447.511	*	91
=	72.57

2. In Ben Graham's calculation of liquidation value, Synmosa Biopharma's accounts receivable are only considered to be worth 75% of book value:

Synmosa Biopharma's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3136.461	-	4363.994	+	0.75 * 1151.151	+	0.5 * 1855.738
=	564

Synmosa Biopharma Change In Receivables Related Terms

Thank you for viewing the detailed overview of Synmosa Biopharma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Synmosa Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synmosa Biopharma Corp (ROCO:4114) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6, Gongye 1st Road, Hukou Township, Hsinchu County, Hsinchu, TWN

Website

https://www.synmosa.com.tw

Synmosa Biopharma Corp is engaged in the research and development, manufacturing, marketing, and distribution of pharmaceutical products, medical devices, cosmetics, animal drugs, chemical food additives, and beverages. It is also involved in manufacturing and sales, and environmental drugs wholesale (retail), as well as the import and export of related businesses. The company provides prescription, OTC medicines, and healthcare products under its Synmosa trademark. The reporting segments of the company are; the Generic Drugs segment which derives key revenue, and the Active Pharmaceutical Ingredients segment.

Synmosa Biopharma Headlines

No Headlines